Separate names with a comma.
MindMed March 8, 2023 1:30 p.m. ET TD Cowen Health Care Conference https://wsw.com/webcast/cowen132/mnmd/2007768
MindMed Reports Full Year 2022 Financial Results and Business Highlights...
$SWISF is moving on low volume... Seriously give this chart a look. https://stockcharts.com/c-sc/sc?s=SWISF&p=D&b=5&g=0&i=0&r=1678157046123 [IMG]
Mike the Pike Entertainment@MTPPRODS $MIKP as well- We are prepared to subscribe to OTCIQ so that we may expedite OTCM requirements and submit...
MindMed CEO Rob Barrow lays out the Company's upcoming milestones and strategy in a new interview with Edison Group [MEDIA]
Cleveland Clinic & MindMed! [MEDIA]
CNBC covering Psychedelics Psychedelics such as psilocybin, ketamine, LSD and MDMA are lately being discussed because of their alleged potential...
Sekur Private Data Ltd. - Preparing for NASDAQ Listing (CSE: SKUR / OTCQX: SWISF / FRA: GDTO) BUY Current Price: C$0.09 Fair Value: C$0.83...
February 2023 Investor Deck https://mindmed.co/wp-content/uploads/2023/02/MindMed-Investor-Presentation_Feb2023.pdf
$MIKP You think you know #vampirella? Check out the Vampirella universe at https://arowanamedia.com/vampirella-universe/… - download the IP...
$MIKP shareholders- it may seem like Groundhog day but PCAOB auditors are backed up like crazy-- per auditor-we should able to file Form 10 w...
Keep an eye on this one. Slow climb started.
[IMG]
Psychedelics May Be Part of U.S. Medicine Sooner Than You Think https://time.com/6253702/psychedelics-psilocybin-mdma-legalization/ BY JAMIE...
Time to jump back in this one! Should start moving again Q1. Hitting lows and stable barcoding starting. :)
High Level of coverage over the past month on YouTube and other areas... https://www.youtube.com/results?search_query=swisf&sp=EgIIBA%253D%253D
Sekur Private Data Ltd. is a Cybersecurity and Internet privacy provider of Swiss hosted solutions for secure and private communications. The...
Reversal inbound Keep an eye on this one. https://finance.yahoo.com/news/agile-therapeutics-announces-distribution-series-213000047.html
AGRX Agile Therapeutics Announces Distribution of Series C Preferred Stock to its Holders of Common Stock...
Basel initiates a new DMT study Phase 1 https://clinicaltrials.gov/ct2/show/NCT05695495 Acute Dose-dependent Effects of DMT-bolus Applications in...
